2012 | |
---|---|
Criterium: | Position: |
Overall Score: | 900-1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | 400-500 |
Total Number of Projects: | 700-800 |
Total Project Funding: | 400-500 |
Networking Rank (Reputation): | 800-900 |
Partner Constancy: | > 1000 |
Project Leadership Index: | > 1000 |
Diversity Index: | > 1000 |
2010 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2009 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total Project Funding: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Partner Constancy: | > 1000 |
Project Leadership Index: | > 1000 |
Diversity Index: | > 1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total Project Funding: | > 1000 |
Partner Constancy: | > 1000 |
Project Leadership Index: | > 1000 |
Diversity Index: | > 1000 |
2007 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total Project Funding: | > 1000 |
Partner Constancy: | > 1000 |
Project Leadership Index: | > 1000 |
Diversity Index: | > 1000 |
Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2012 | 0 | 5.999.389 | 535.770 | 2 | ||
2011 | 0 | 32.870.022 | 2.198.485 | 4 | ||
2010 | 0 | 1.319.990 | 100.410 | 1 |
Total number of partners: 88
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 88
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2012-01-01 | OPtimizing TArgets and Therapeutics In high risk and refractOry Multiple Myeloma | OPTATIO | participant | 2.999.529 | 12 |
2012-01-01 | Targeting Src-family tyrosine kinases in chronic autoimmune and inflammatory diseases | TARKINAID | participant | 2.999.860 | 11 |
2011-12-01 | PRIMES: Protein interaction machines in oncogenic EGF receptor signalling | PRIMES | participant | 11.999.640 | 14 |
2011-06-01 | Innovative anti-influenza drugs excluding viral escape | ANTIFLU | participant | 5.999.998 | 11 |
2011-02-01 | More Medicines for Tuberculosis | MM4TB | participant | 11.873.052 | 25 |
2011-01-01 | New approaches for the targeted therapy of Non-Small Cell Lung Cancer | LUNGTARGET | participant | 2.997.332 | 10 |
2010-01-01 | Novel strategies for the prevention and control of persistent infections | NOPERSIST | participant | 1.319.990 | 12 |